Board Committee changes

RNS Number : 6618I

GlaxoSmithKline PLC

10 December 2015

 

GlaxoSmithKline plc

Board Committee changes

GlaxoSmithKline plc (the "Company") announces that Vindi Banga, Senior Independent Director designate and Independent Non-Executive Director, has been appointed a member of the Audit & Risk, Nominations and Remuneration Committees with effect from 1 January 2016.

V A Whyte

Company Secretary

10 December 2015

 

END

 

 

BOAPKKDQDBDDFBD